ATC Group: A06AA02 Docusate sodium

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of A06AA02 in the ATC hierarchy

Level
Code
Title
1
Alimentary tract and metabolism
2
Laxatives
3
Laxatives
4
Softeners, emollients
5
A06AA02
Docusate sodium

Defined daily dose

The DDD is the assumed average maintenance dose per day for a drug used for its main indication in adults. The DDD is a unit of measurement and does not necessarily reflect the recommended or Prescribed Daily Dose. Therapeutic doses for individual patients and patient groups will often differ from the DDD as they will be based on individual characteristics (such as age, weight, ethnic differences, type and severity of disease) and pharmacokinetic considerations.

Route
Amount
ORAL - Oral
0.15 g

Active ingredients in A06AA02

Active Ingredient
Description

Docusate is an anionic wetting agent, which acts as a faecal softener by lowering the surface tension and allowing penetration of accumulated hard dry faeces by water and salts. Docusate sodium also possesses stimulant activity.

Medicines in this ATC group

Drug
Countries

Canada

Australia New Zealand

United Kingdom

United Kingdom

United Kingdom

Tunisia

New Zealand

Poland

Tunisia

Canada

Canada Hong Kong

Australia Ireland New Zealand South Africa United Kingdom ...

Related product monographs

Title
Type
Country
Summary of Product Characteristics (SPC)
UK
Summary of Product Characteristics (SPC)
UK